Summary
Lysostaphin, a staphylococcus-derived staphylocidal substance, has widely been used in assays of granulocyte phagocytic and bactericidal capability. It rapidly kills extracellular bacteria. Thus, a separate determination of intracellular surviving bacteria can be performed. One prerequisite for this approach is the safe inactivation of lysostaphin (usually brought about by trypsin) before the intracellular bacteria are externalized for plating. This inactivation has been found by others to be incomplete. Data are presented demonstrating a safe inactivation of lysostaphin by trypsin, if the pH value is maintained within the alkaline range. A low variation of results is obtained by plotting the total number of bacteria killed per incubate vs the logarithm of initial bacterial inoculum or of the intracellular surviving bacteria, leading to linear regression lines. The variation of the results increases greatly for initial bacteria/granulocyte proportions of > 5/1. The results obtained for two differentSt. aureus strains are significantly different. Dexamethasone pretreatment (12 mg p.o. within 8 h) had no detectable influence, when fresh blood was assayed, while blood storage at room temperature for 12 h (without dexamethasone pretreatment) led to a significant functional impairment, mainly of bactericidal capability when analyzed in a pairwise fashion. A major limitation of this kind of assays is that killed bacteria cannot be determined directly.
Similar content being viewed by others
Abbreviations
- HBSS:
-
Hanks balanced salt solution
- PBS:
-
Phosphate buffered saline
- PMN:
-
Polymorphonuclear granulocytes granulocytes
- RBC:
-
Red blood cells
References
Bültmann B, Geitner R, Seibold H, Kratsch G, Haferkamp O (1980) Interaction of circulating immune complexes with granulocyte function in patients with rheumatoid arthritis. Klin Wochenschr 58:727–732
Clawson CC, Repine JE (1976) Quantitation of maximal bactericidal capability in human neutrophils. J Lab Clin Med 88:316–321
Dörner J, Blobel H, Schaeg W (1977) Auswertung der Phagocytose von Staphylokokken unter Verwendung von Lysostaphin. Zentralbl Bakteriol Mikrobiol Hyg [A] 237:141–146
Douglas St, Davis WC, Fudenberg H (1969) Granulocytopathies: pleomorphism of neutrophil dysfunction. Am J Med 46:901–909
Easmon CSF, Lanyon H, Cole PJ (1978) Use of lysostaphin to remove cell-adherent staphylococci during in vitro assays of phagocytic function. Br J Exp Pathol 58:381–385
Gallin JI, Bujak JS, Patten E, Wolf SM (1974) Granulocyte function in the Chediak-Higashi syndrome of mice. Blood 43:201–206
Glasser L, Huestis DW, Jones JF (1977) Functional capabilities of steroid-recruited neutrophils harvested for clinical transfusion. New Engl J Med 297:1033–1036
Grov A, Iversen OJ, Endresen C (1974) Studies on lysostaphin. Serological cross-reactions between three isolated enzymes. Eur J Biochem 48:193–198
Hays WL (1974) Statistics for social sciences, 2nd edn. Holt, Rinehart and Winston, London New York Sydney Toronto
Iversen OJ, Grov A (1973) Studies on lysostaphin separation and characterisation of three enzymes. Eur J Biochem 38:239–300
Klock JC, Bainton DF (1976) Degranulation and abnormal bactericidal function of granulocytes procured by reversible adhesion to nylon wool. Blood 48:149–161
Koch CH (1974) Neutrophil granulocyte function in vitro. Acta Path Microbiol Immunol Scand [B] 82:127–135
McCullough J, Carter SJ, Quie PG (1974) Effects of anticoagulants and storage on granulocyte function in bank blood. Blood 43:207–217
McCullough J, Weiblen BJ, Peterson PhK, Quie PG (1978) Effects of temperature on granulocyte preservation. Blood 52:301–310
Moser R, Meuret G, Senn HJ (1970) Funktionelle Veränderungen durch Konditionierung und Filtrations-Leukapherese? Blut 41:347–357
Peterson PK, Vershoef J, Quie PG (1977) Influence of temperature on opsonization and phagocytosis of staphylococci. Infect Immun 15:175–181
Price ThH, Dale DC (1979) Blood kinetics and in vitro chemotaxis of transfused neutrophils: effect of collection method, donor corticoid treatment, and short-term storage. Blood 54:977–986
Prudzanski W, Saito S, Nitzan D (1983) The influence of lysostaphin on phagocytosis, intracellular bactericidal activity, and chemotaxis of human polymorphonuclear cells. J Lab Clin Med 102:298–305
Schindler CA, Schuhardt VT (1964) Lysostaphin: a new bacteriolytic agent for the staphylococcus. Proc Nat Acad Sci 51:414–421
Shoji M, Vogler WR (1974) Effects of hydrocortisone on the yield and bactericidal function of granulocytes collected by continuous-flow centrifugation. Blood 44:435–443
Sloan GL, Smith EC, Lancaster JH (1977) Lysostaphin endopeptidase-catalyzed transpeptidation reactions of the imino-transfer type. Biochem J 167:293–296
Tan JS, Watanakunakorn C, Phair JP (1971) A modified assay of neutrophil function: use of lysostaphin to differentiate defective phagocytosis from impaired intracellular killing. J Lab Clin Med 78:316–322
Urbanitz D, Basedow M, Adamczak M, Borberg H (1978) NBT-Test: Anwendung bei der Leukapherese, bei Fieber, bakterieller Genese, bei malignen Neoplasien. Blut 37:158 (Abstr)
Van den Broek PJ, Dehue FAM, Leih PCJ, van den Barselaer MTh, van Furth R (1982) The use of lysostaphin in in vitro assay of phagocyte functions: adherence to and penetration into granulocytes. Scand J Immunol 15:467–473
Van den Broek PJ, Buys LFM, van Furth R (1985) Adherence of lysostaphin to and penetration into human monocytes. Scand J Immunol 21:189–193
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Urbanitz, D., Schneider, R., Meier, M. et al. Lysostaphin-based assay of human granulocyte functions: A reevaluation. Klin Wochenschr 64, 1029–1035 (1986). https://doi.org/10.1007/BF01757210
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01757210